For the BPL1 treatment, it was reported that there were reductions in abdominal adiposity in a subgroup of PWS individuals that were older than 4.5 years, and BPL1 improved fasting insulin concentration and insulin sensitivity (46). The gene discussed is INS; the disease is Prader-Willi syndrome.